Of the three tumors with HER3 amplification, one tumor presented with normal EGFR, HER2 and HER3 CN, one tumor had normal EGFR and HER3 CN and HER2 low gain, while one of the three HER3 amplified tumors was non-informative regarding CN status. Here, EGFR is linked to neoplasm.